The influence of different adjuvants on the immune response to a synthetic peptide comprising amino acid residues 9–21 of herpes simplex virus type 1 glycoprotein D
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 124 (1) , 95-102
- https://doi.org/10.1016/0022-1759(89)90190-7
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coliArchiv für die gesamte Virusforschung, 1988
- Adjuvants: A Real Shot in the Arm for Recombinant VaccinesNature Biotechnology, 1988
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.The Journal of Experimental Medicine, 1987
- Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexesVaccine, 1985
- Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in MiceScience, 1985
- Protection from Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein DScience, 1985
- Vaccine AdjuvantsClinical Infectious Diseases, 1980
- Anti-inflammatory mechanism of inflamed-tissue factorInflammation Research, 1973
- Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of InfantsBMJ, 1969